RESULTS OF TOTAL LAPAROSCOPIC GASTRECTOMY WITH D2 LYMPHADENECTOMY FOLLOWED BY ROUX-EN-Y RECONSTRUCTION FOR GASTRIC ADENOCARCINOMA AT HANOI MEDICAL UNIVERSITY HOSPITAL

Hoàng Nguyễn, Tú Anh Nguyễn

Main Article Content

Abstract

Objectives: To describe the clinical, paraclinical, pathology and early results of total laparaoscopic distal gastrectomy with D2 lymphadenectomy followed by intracorporelal Roux en Y recontraction for carcinoma of the stomach from June 2021 to June 2023 at Hanoi Medical University Hospital. Method: A retrospective descriptive study on 61 patients with gastric carcinoma who underwent total laparoscopic distal gastrectomy with D2 lymphadenectomy followed by intracorporelal Roux en Y recontraction. Results and discussion: The average age was 63.82 ± 10.4 years (31- 83 years). 70.05% was male. Common reasons for coming to the doctor are epigastric pain (85.25%) and weight loss (40.98%). The most common tumor is in the pyloric antrum (77.05%). The average tumor size was 3.23 ± 1.91 cm The average surgery time is 191.64 ± 45.37 minutes (100 - 360 minutes) depending on the physical condition, level of invasion and anastomosis technique of making anastomosis). No complications were recorded during surgery. The average postoperative hospital stay (SM) is 7.90 ± 3.12 days (4 - 21 days). The rate of complications after surgery was 13.11%, of which complications of acute pancreatitis were the most common, with no cases of death during or after surgery. Histopathological results were mainly adenocarcinoma (77.05%). The average number of lymph nodes dredged was 30.84 lymph nodes, the average number of metastatic lymph nodes was 3.39 ± 4.70 lymph nodes. Conclusions: total laparoscopic distal gastrectomy with D2 lymphadenectomy followed by intracorporelal Roux en Y recontraction is a safe and effective method in the treatment of gastric carcinoma.

Article Details

References

1. Ajani JA, D’Amico TA, Bentrem DJ, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20(2):167-192. doi:10.6004/ jnccn.2022.0008
2. Morgan E, Arnold M, Camargo MC, et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study. eClinicalMedicine. 2022;47:101404. doi:10.1016/ j.eclinm.2022.101404
3. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660
4. Ma G. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2020;24:1-21. doi:10.1007/s10120-020-01042-y
5. Kitano S, Shiraishi N, Uyama I, Sugihara K, Tanigawa N, Japanese Laparoscopic Surgery Study Group. A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann Surg. 2007;245(1):68-72. doi:10.1097/01.sla.0000225364.03133.f8
6. Ramos MFKP, Pereira MA, Dias AR, Ribeiro Jr U, Zilberstein B, Nahas SC. Laparoscopic gastrectomy for early and advanced gastric cancer in a western center: a propensity score-matched analysis. Updat Surg. 2021;73(5):1867-1877. doi:10.1007/s13304-021-01097-1
7. Park JH, Jeong SH, Lee YJ, et al. Comparison of long-term oncologic outcomes of laparoscopic gastrectomy and open gastrectomy for advanced gastric cancer: A retrospective cohort study. Korean J Clin Oncol. 2018;14:21-29. doi:10. 14216/kjco.18004
8. Emam HMK, Moussa EMM, Abouelmaged M, Ibrahim MRI. Role of Multidetector CT in Staging of Gastric Carcinoma. J Cancer Ther. 2019;10(07):565-579. doi:10.4236/jct.2019.107046
9. Cianchi F, Indennitate G, Trallori G, et al. Robotic vs laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer: a retrospective comparative mono-institutional study. BMC Surg. 2016;16(1):65. doi:10.1186/ s12893-016-0180-z
10. Zhao LY, Zhang WH, Chen XZ, et al. Prognostic Significance of Tumor Size in 2405 Patients With Gastric Cancer: A Retrospective Cohort Study. Medicine (Baltimore). 2015;94(50): e2288. doi:10.1097/MD.0000000000002288